Octant Bio
Emeryville, USA· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Synthetic biology platform using engineered cells and data science to map disease biology and discover new drugs.
ImmunologyMetabolic DiseaseNeuroscience
Technology Platform
Synthetic biology platform that engineers human cells to report on multiple biological pathways simultaneously, integrated with machine learning for drug discovery and target identification.
Opportunities
Potential to identify first-in-class therapeutics for diseases with poorly understood biology by mapping complex cellular networks.
Risk Factors
Risk that its platform's predictions may not translate to human clinical outcomes, and dependency on partnerships for pipeline advancement.
Competitive Landscape
Competes with synthetic biology and high-throughput screening companies, but differentiates through its multiplexed, pathway-focused approach to complex diseases.